JMP Securities Reiterates Market Outperform on BioAtla, Maintains $5 Price Target
Portfolio Pulse from Benzinga Newsdesk
JMP Securities has reiterated a Market Outperform rating for BioAtla (NASDAQ:BCAB) and maintained a $5 price target.
September 16, 2024 | 1:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities has reiterated its Market Outperform rating for BioAtla, maintaining a $5 price target, indicating confidence in the company's potential.
The reiteration of a Market Outperform rating and maintenance of a $5 price target by JMP Securities suggests a positive outlook for BioAtla. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100